Curefit will be tested

Mukesh Bansal’s Curefit has all the funding it needs, but little semblance of a strategy.

Since long before it became commonplace for venture capital investors to publicly praise their portfolio companies, Vani Kola, the managing director of Kalaari Capital, has been building up Mukesh Bansal. At conferences where Kola speaks about the ecosystem, she’s often called Bansal the smartest entrepreneur in India. Other names that would feature sometimes are Kunal Bahl of Snapdeal and more recently Harsh Jain of Dream11, but Bansal is a constant fixture.

Kola and Bansal go back more than a decade, when late in 2007, Indo-US Ventures (now Kalaari Capital) put a tiny cheque into Bansal’s fashion e-commerce startup Myntra. Some …

Author

Harveen Ahluwalia

Harveen is a co-founder at The Morning Context, and leads our Internet coverage, overseeing a team of reporters writing on startups and tech. She has previously worked as a media, consumer and tech reporter at The Ken and Mint. At The Morning Context, she writes on startups, venture capital, consumer and media businesses—from e-commerce to healthtech to streaming.

Editor, Internet

harveen@mailtmc.com

Mumbai